Vicarious Surgical (NYSE:RBOT) Price Target Lowered to $10.50 at Piper Sandler

by · The Cerbat Gem

Vicarious Surgical (NYSE:RBOT – Free Report) had its target price trimmed by Piper Sandler from $12.00 to $10.50 in a research report sent to investors on Wednesday morning,Benzinga reports. The firm currently has a neutral rating on the stock.

Vicarious Surgical Price Performance

Shares of NYSE RBOT opened at $8.90 on Wednesday. The company has a market capitalization of $52.51 million, a price-to-earnings ratio of -0.91 and a beta of 1.02. Vicarious Surgical has a 1 year low of $4.27 and a 1 year high of $21.43. The business has a 50-day moving average of $6.89 and a two-hundred day moving average of $7.63.

Vicarious Surgical (NYSE:RBOT – Get Free Report) last released its quarterly earnings results on Monday, August 12th. The company reported ($2.86) EPS for the quarter, topping the consensus estimate of ($2.98) by $0.12. As a group, equities research analysts expect that Vicarious Surgical will post -10.07 earnings per share for the current year.

Vicarious Surgical Company Profile

(Get Free Report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Further Reading